Joincare Pharmaceutical Group Industry Co., Ltd
Clinical trials sponsored by Joincare Pharmaceutical Group Industry Co., Ltd, explained in plain language.
-
New COPD pill aims to cut Flare-Ups in half?
Disease control Recruiting nowThis study tests a new tablet called JKN2403 in 120 adults with moderate-to-severe COPD. Participants take the drug or a placebo daily for 24 weeks to see if it reduces serious flare-ups and improves breathing and quality of life. The goal is to better control the disease, not cu…
Phase: PHASE2 • Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New Kids' flu drug could shorten sick days
Symptom relief Recruiting nowThis study tests a new flu medicine (JKN2301) in children aged 2 to 11 who have the flu. The goal is to see if it safely reduces symptoms like fever and cough faster than existing treatments. About 177 kids will take part, and researchers will monitor side effects and recovery ti…
Phase: PHASE3 • Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd • Aim: Symptom relief
Last updated May 08, 2026 12:03 UTC
-
New antibiotic candidate JKN2501 begins first human safety tests
Knowledge-focused Recruiting nowThis early-stage study is testing a new drug called JKN2501 in 66 healthy adults in China to see if it is safe and how the body processes it. Participants will receive either the drug or a placebo by IV, and researchers will monitor for side effects and measure drug levels in blo…
Phase: PHASE1 • Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC